- Title: Subtitle
- National network of depression centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder
- Creators
- Mark J. Niciu - University of IowaRobert C. Meisner - Harvard UniversityBrent R. Carr - Florida CollegeAli A. Farooqui - University of LouisvilleDavid Feifel - Neuropsychiatric Research InstituteAdam KaplinE. Jeremy Kendrick - University of UtahPaul M. KimChristopher D. Schneck - University of Colorado Anschutz Medical CampusJennifer L. Vande VoortSagar V. Parikh - University of Michigan–Ann Arbor
- Resource Type
- Letter/Communication
- Publication Details
- Journal of affective disorders, Vol.346, pp.221-222
- DOI
- 10.1016/j.jad.2023.11.008
- PMID
- 37940059
- ISSN
- 0165-0327
- eISSN
- 1573-2517
- Grant note
- DOI: 10.13039/100000027, name: National Institute on Alcohol Abuse and Alcoholism
- Language
- English
- Electronic publication date
- 11/2023
- Date published
- 02/2024
- Academic Unit
- Psychiatry; Iowa Neuroscience Institute
- Record Identifier
- 9984506358602771
Letter/Communication
National network of depression centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder
Journal of affective disorders, Vol.346, pp.221-222
02/2024
DOI: 10.1016/j.jad.2023.11.008
PMID: 37940059
Details
Metrics
14 Record Views